Brendan Melck is a Senior Research Analyst in the Life Sciences team, specializing in Germany, Central and Eastern Europe, the Balkans and Greece. He is responsible for daily updates on regulatory and business developments affecting the pharmaceutical industry, as well as in-depth reports on specific topics and markets. In ten years covering the same regions, he has acquired a long-term view of the specific regulatory issues affecting these markets. Previously, Brendan worked for six years as an analyst for Esmerk (now mBrain, formerly part of the Finnish Sanoma media group), covering the Polish market. Previously, he worked in the education sector, as a teacher of English as a foreign language. He has a BA in English and History from the University of London and is fluent German and Polish.